| PRKCA (PKCa) | PKC | AGC | 4ra4 | A | | (1r)-9-[(3s,4s)-1,3-dimethylpiperidin-4-yl]-8-(2-fluorophenyl)-1-methyl-3,5-dihydro[1,2,4]triazino[3,4-c][1,4]benzoxazin-2(1h)-one | Human | 3040 | 0.53 | |
| PRKCQ (PKCt) | PKC | AGC | 4ra5 | B | A | (1r)-9-[(1,3-dimethylazetidin-3-yl)(methyl)amino]-1-methyl-8-phenyl-3,5-dihydro[1,2,4]triazino[3,4-c][1,4]benzoxazin-2(1h)-one | Human | 5361 | 1.00 | |
| PRKCQ (PKCt) | PKC | AGC | 4q9z | A | A | (1r)-9-(azetidin-3-ylamino)-1,8-dimethyl-3,5-dihydro[1,2,4]triazino[3,4-c][1,4]benzoxazin-2(1h)-one | Human | 5356 | 0.46 | |
| PRKCQ (PKCt) | PKC | AGC | 4ra5 | A | B | (1r)-9-[(1,3-dimethylazetidin-3-yl)(methyl)amino]-1-methyl-8-phenyl-3,5-dihydro[1,2,4]triazino[3,4-c][1,4]benzoxazin-2(1h)-one | Human | 5359 | 1.00 | |
| PRKCQ (PKCt) | PKC | AGC | 4ra5 | B | B | (1r)-9-[(1,3-dimethylazetidin-3-yl)(methyl)amino]-1-methyl-8-phenyl-3,5-dihydro[1,2,4]triazino[3,4-c][1,4]benzoxazin-2(1h)-one | Human | 5360 | 1.00 | |
| PRKCQ (PKCt) | PKC | AGC | 4q9z | B | B | (1r)-9-(azetidin-3-ylamino)-1,8-dimethyl-3,5-dihydro[1,2,4]triazino[3,4-c][1,4]benzoxazin-2(1h)-one | Human | 5362 | 0.46 | |
| PRKCQ (PKCt) | PKC | AGC | 4ra5 | A | A | (1r)-9-[(1,3-dimethylazetidin-3-yl)(methyl)amino]-1-methyl-8-phenyl-3,5-dihydro[1,2,4]triazino[3,4-c][1,4]benzoxazin-2(1h)-one | Human | 5354 | 1.00 | |
| PRKCQ (PKCt) | PKC | AGC | 4q9z | B | A | (1r)-9-(azetidin-3-ylamino)-1,8-dimethyl-3,5-dihydro[1,2,4]triazino[3,4-c][1,4]benzoxazin-2(1h)-one | Human | 5355 | 0.46 | |
| PRKCQ (PKCt) | PKC | AGC | 4q9z | A | B | (1r)-9-(azetidin-3-ylamino)-1,8-dimethyl-3,5-dihydro[1,2,4]triazino[3,4-c][1,4]benzoxazin-2(1h)-one | Human | 5353 | 0.46 | |
